营业总收入
Search documents
厦门空港(600897.SH):2025年三季报净利润为3.84亿元、同比较去年同期上涨3.53%
Xin Lang Cai Jing· 2025-10-31 02:08
Core Insights - Xiamen Airport (600897.SH) reported a total operating revenue of 1.523 billion yuan for Q3 2025, an increase of 102 million yuan compared to the same period last year, marking a 7.21% year-on-year growth and achieving three consecutive years of increase [1] - The net profit attributable to shareholders reached 384 million yuan, up by 13.1 million yuan year-on-year, reflecting a 3.53% increase and also achieving three consecutive years of growth [1] - The net cash inflow from operating activities was 530 million yuan, an increase of 30.32 million yuan year-on-year, representing a 6.07% growth and three consecutive years of increase [1] Financial Ratios - The latest debt-to-asset ratio stands at 17.21%, ranking first among disclosed peers, with a decrease of 1.82 percentage points from the previous quarter [3] - The latest gross profit margin is 37.82%, also ranking first among disclosed peers, with an increase of 1.79 percentage points compared to the same period last year, achieving three consecutive years of growth [3] - The latest return on equity (ROE) is 8.15%, ranking fifth among disclosed peers [3] - The diluted earnings per share (EPS) is 0.92 yuan, ranking second among disclosed peers, with an increase of 0.03 yuan year-on-year, reflecting a 3.54% growth and three consecutive years of increase [3] - The total asset turnover ratio is 0.26 times, remaining stable compared to the same period last year, with a year-on-year increase of 0.39% [3] - The inventory turnover ratio is 1375.47 times, ranking first among disclosed peers [3] Shareholder Structure - The number of shareholders is 16,500, with the top ten shareholders holding 307 million shares, accounting for 73.55% of the total share capital [3] - The largest shareholder is Xiamen Xiangye Group Co., Ltd., holding 68.00% of the shares [3]
华茂股份(000850.SZ):2025年三季报净利润为1.72亿元、同比较去年同期上涨12.84%
Xin Lang Cai Jing· 2025-10-31 01:56
Group 1 - The company's total operating revenue for Q3 2025 is 2.545 billion yuan, ranking 12th among disclosed peers, with an increase of 24.8478 million yuan compared to the same period last year, representing a year-on-year growth of 0.99% [1] - The net profit attributable to shareholders is 172 million yuan, ranking 11th among disclosed peers, with an increase of 19.529 million yuan compared to the same period last year, achieving a year-on-year growth of 12.84% [1] - The net cash flow from operating activities is 426 million yuan, ranking 9th among disclosed peers, with an increase of 302 million yuan compared to the same period last year, representing a year-on-year growth of 244.91% [1] Group 2 - The company's latest debt-to-asset ratio is 36.64%, a decrease of 0.48 percentage points from the previous quarter [3] - The latest gross profit margin is 10.76% [3] - The latest return on equity (ROE) is 3.77%, an increase of 0.27 percentage points compared to the same period last year [3] Group 3 - The diluted earnings per share are 0.19 yuan, an increase of 0.02 yuan compared to the same period last year, achieving a year-on-year growth of 13.25% [3] - The latest total asset turnover ratio is 0.35 times, remaining stable compared to the same period last year, with a year-on-year increase of 0.31 [3] - The latest inventory turnover ratio is 2.53 times, ranking 14th among disclosed peers [3] Group 4 - The number of shareholders is 30,700, with the top ten shareholders holding 479 million shares, accounting for 50.80% of the total share capital [3] - The largest shareholder is Anhui Huamao Group Co., Ltd., holding 46.41% of the shares [3]
国药一致(000028.SZ):2025年三季报净利润为9.57亿元、同比较去年同期下降10.18%
Xin Lang Cai Jing· 2025-10-31 01:56
Core Insights - The company reported a total revenue of 55.124 billion yuan for Q3 2025, ranking 4th among peers, with a year-on-year decrease of 2.38% [1] - The net profit attributable to shareholders was 0.957 billion yuan, ranking 6th among peers, reflecting a year-on-year decline of 10.18% [1] - The net cash flow from operating activities was -0.463 billion yuan, ranking 27th among peers, showing a significant year-on-year decrease of 136.15% [1] Financial Performance - The latest debt-to-asset ratio is 57.39%, ranking 13th among peers, with a decrease of 0.47 percentage points from the previous quarter and 0.96 percentage points from the same period last year [3] - The latest gross profit margin is 10.49%, ranking 20th among peers, down by 0.20 percentage points from the previous quarter and 0.39 percentage points year-on-year [3] - The latest return on equity (ROE) is 5.19%, ranking 14th among peers, with a decrease of 0.69 percentage points from the same period last year [3] Earnings and Ratios - The diluted earnings per share (EPS) is 1.72 yuan, ranking 2nd among peers, representing a year-on-year decrease of 9.95% [3] - The total asset turnover ratio is 1.12 times, ranking 6th among peers, with a slight decrease of 0.01 times year-on-year [3] - The inventory turnover ratio is 6.27 times, ranking 5th among peers, showing an increase of 1.99% year-on-year, marking three consecutive years of growth [3] Shareholder Structure - The number of shareholders is 41,400, with the top ten shareholders holding 345 million shares, accounting for 62.05% of the total share capital [3] - The largest shareholder is China National Pharmaceutical Group Co., Ltd., holding 56.06% of the shares [3]
宏盛股份(603090.SH):2025年三季报净利润为6437.67万元
Xin Lang Cai Jing· 2025-10-31 01:56
Core Insights - Hongsheng Co., Ltd. (603090.SH) reported a total operating revenue of 554 million yuan for Q3 2025, ranking 139th among disclosed peers [1] - The net profit attributable to shareholders was 64.38 million yuan, with net cash inflow from operating activities at 77.53 million yuan, a decrease of 10.07 million yuan or 11.50% year-on-year [1][3] Financial Performance - The latest debt-to-asset ratio stands at 30.85%, an increase of 1.74 percentage points compared to the same period last year [3] - The gross profit margin is 25.50%, ranking 134th among disclosed peers, down 1.26 percentage points from the previous quarter and 1.76 percentage points year-on-year [3] - Return on equity (ROE) is reported at 10.50% [3] - The diluted earnings per share (EPS) is 0.64 yuan [3] - Total asset turnover ratio is 0.62 times, a decrease of 0.01 times year-on-year, reflecting a decline of 1.13% [3] - Inventory turnover ratio is recorded at 3.12 times [3] Shareholder Structure - The number of shareholders is 13,300, with the top ten shareholders holding a total of 60.01% of the total share capital, amounting to 60.01 million shares [3] - The largest shareholder is Niu Yuxia, holding 47.6% of the shares [3]
方正证券(601901.SH):2025年三季报净利润为37.99亿元
Xin Lang Cai Jing· 2025-10-31 01:48
Core Insights - The company reported a total operating revenue of 9.082 billion yuan and a net profit attributable to shareholders of 3.799 billion yuan for Q3 2025 [1] - The net cash inflow from operating activities was -1.04 billion yuan, ranking 40th among disclosed peers, with a significant decrease of 6.752 billion yuan compared to the same period last year, representing a year-on-year decline of 118.21% [1] - The company's latest debt-to-asset ratio stands at 80.39%, ranking 37th among peers, with an increase of 0.54 percentage points from the same period last year [3] - The return on equity (ROE) is reported at 7.54% [3] - The diluted earnings per share (EPS) is 0.46 yuan [4] - The total asset turnover ratio is 0.04 times [5] - The number of shareholders is 195,300, with the top ten shareholders holding 5.14 billion shares, accounting for 62.44% of the total share capital [5] Shareholding Structure - The largest shareholder is New Founder Holdings Development Co., Ltd., holding 28.71% [5] - The second-largest shareholder is the National Social Security Fund Council, with a holding of 13.24% [5] - Other significant shareholders include China Cinda Asset Management Co., Ltd. (7.20%), Hong Kong Central Clearing Limited (4.38%), and Harbin Hato Investment Co., Ltd. (2.40%) [5]
华西股份(000936.SZ):2025年三季报净利润为3.29亿元、同比较去年同期上涨132.98%
Xin Lang Cai Jing· 2025-10-31 01:45
Core Insights - The company reported a total operating revenue of 2.533 billion yuan for Q3 2025, an increase of 22.17 million yuan compared to the same period last year, marking a year-on-year growth of 0.88% [1] - The net profit attributable to shareholders reached 329 million yuan, an increase of 188 million yuan year-on-year, representing a significant growth of 132.98% [1] - The net cash inflow from operating activities was 181 million yuan, up by 170 million yuan from the previous year, achieving a year-on-year increase of 1543.11% [1] Financial Ratios - The latest debt-to-asset ratio stands at 25.40%, ranking 5th among disclosed peers [3] - The gross profit margin is 8.44%, which is an increase of 0.98 percentage points from the previous quarter and an increase of 2.84 percentage points year-on-year [3] - The return on equity (ROE) is 6.15%, ranking 5th among disclosed peers, with a year-on-year increase of 3.68 percentage points [3] Earnings Per Share and Turnover - The diluted earnings per share (EPS) is 0.37 yuan, an increase of 0.21 yuan year-on-year, reflecting a growth of 131.25% [3] - The total asset turnover ratio is 0.36 times, while the inventory turnover ratio is 5.83 times, ranking 4th among disclosed peers [3] Shareholder Structure - The number of shareholders is 66,200, with the top ten shareholders holding a total of 374 million shares, accounting for 42.26% of the total share capital [3] - The largest shareholder is Jiangsu Huaxi Group Co., Ltd., holding 29.3% of the shares [3]
澳洋健康(002172.SZ):2025年三季报净利润为4011.37万元
Xin Lang Cai Jing· 2025-10-31 01:37
Core Insights - The company reported a total revenue of 1.36 billion yuan for Q3 2025, a decrease of 141 million yuan compared to the same period last year, representing a year-on-year decline of 9.39% [1] - The net profit attributable to shareholders was 40.11 million yuan, ranking 26th among disclosed peers [1] - The company experienced a negative cash flow from operating activities amounting to -28.66 million yuan, ranking 45th among disclosed peers [1] Financial Metrics - The latest debt-to-asset ratio is 91.97%, ranking 51st among disclosed peers [3] - The gross profit margin is 14.27%, ranking 48th, with a decrease of 0.57 percentage points from the previous quarter [3] - The return on equity (ROE) is 22.97%, down 6.21 percentage points compared to the same period last year [3] - The diluted earnings per share (EPS) is 0.05 yuan, ranking 33rd among disclosed peers [3] - The total asset turnover ratio is 0.68 times, a decrease of 0.04 times year-on-year, representing a decline of 4.98% [3] - The inventory turnover ratio is 8.24 times [3] Shareholder Structure - The number of shareholders is 58,300, with the top ten shareholders holding a total of 276 million shares, accounting for 36.02% of the total share capital [3] - The largest shareholder is Aoyang Group Co., Ltd., holding 30.7% of the shares [3] - Other notable shareholders include Shen Qing (2.24%), Tui Jian (1.31%), and Li Anming (0.37%) [3]
众生药业(002317.SZ):2025年三季报净利润为2.51亿元
Xin Lang Cai Jing· 2025-10-31 01:37
Core Insights - The company reported a total revenue of 1.889 billion yuan for Q3 2025, a decrease of 19.2682 million yuan compared to the same period last year, representing a year-on-year decline of 1.01% [1] - The net profit attributable to shareholders was 251 million yuan, while the net cash inflow from operating activities was 155 million yuan, ranking 38th among disclosed peers, and decreased by 145 million yuan year-on-year, a decline of 48.42% [1] Financial Metrics - The latest debt-to-asset ratio stands at 20.16% [3] - The latest gross profit margin is 56.80%, down by 1.27 percentage points from the previous quarter [3] - The return on equity (ROE) is reported at 6.22% [3] - The diluted earnings per share (EPS) is 0.30 yuan [3] - The total asset turnover ratio is 0.35 times, and the inventory turnover ratio is 2.06 times [3] Shareholder Information - The number of shareholders is 72,900, with the top ten shareholders holding a total of 282 million shares, accounting for 33.24% of the total share capital [3] - The top shareholders include: - Zhang Yuchong: 10.91% - Zhang Yuli: 10.91% - Hong Kong Central Clearing Limited: 2.66% - Industrial Bank Co., Ltd. - Xingquan Trend Investment Mixed Securities Investment Fund: 1.94% - Chen Yonghong: 1.61% - China Merchants Bank Co., Ltd. - Xingquan He Run Mixed Securities Investment Fund: 1.28% - China Construction Bank Co., Ltd. - Xingquan Multi-Dimensional Value Mixed Securities Investment Fund: 1.13% - National Social Security Fund 604 Portfolio: 0.95% - Li Yujian: 0.94% - Bank of China Co., Ltd. - Xingquan He Feng Three-Year Holding Period Mixed Securities Investment Fund: 0.91% [3]
广宇集团(002133.SZ):2025年三季报净利润为9465.22万元
Xin Lang Cai Jing· 2025-10-31 01:37
Core Viewpoint - Guangyu Group (002133.SZ) reported its Q3 2025 financial results, showing a total revenue of 3.9 billion yuan and a net profit attributable to shareholders of 94.65 million yuan, indicating the company's financial performance during the period [1]. Financial Performance - The company's total revenue for Q3 2025 was 3.9 billion yuan [1]. - The net profit attributable to shareholders was 94.65 million yuan [1]. - The net cash inflow from operating activities was 449 million yuan [1]. Financial Ratios - The latest debt-to-asset ratio is 58.93% [3]. - The gross profit margin stands at 9.29%, ranking 73rd among disclosed peers [3]. - The return on equity (ROE) is 3.22% [3]. - The diluted earnings per share (EPS) is 0.01 yuan [3]. - The total asset turnover ratio is 0.44 times [3]. - The inventory turnover ratio is 0.74 times [3]. Shareholder Information - The number of shareholders is 29,300, with the top ten shareholders holding a total of 283 million shares, accounting for 36.59% of the total share capital [3]. - The top ten shareholders and their holdings are as follows: - Hangzhou Pinghai Investment Co., Ltd.: 17.4% - Wang Heming: 9.58% - Hangzhou Lanhua Investment Management Co., Ltd.: 4.26% - Yan Jianguang: 1.44% - Che Lingling: 0.89% - Guangdong Hefeng Private Fund Management Co., Ltd.: 0.74% - Wu Qun: 0.65% - Cao Juning: 0.56% - He Xiaochun: 0.56% - J.P. Morgan Securities PLC: 0.50% [3].
常铝股份(002160.SZ):2025年三季报净利润为3670.16万元、同比较去年同期下降28.54%
Xin Lang Cai Jing· 2025-10-31 01:37
Core Insights - The company reported a total revenue of 6.172 billion yuan for Q3 2025, marking an increase of 550 million yuan compared to the same period last year, representing a year-on-year growth of 9.79% [1] - The net profit attributable to shareholders was 36.7016 million yuan, a decrease of 14.6565 million yuan from the previous year, reflecting a year-on-year decline of 28.54% [1] - The net cash flow from operating activities was -148 million yuan, down 206 million yuan from the same period last year, indicating a significant decline of 355.87% [1] Financial Ratios - The latest debt-to-asset ratio stands at 57.07%, an increase of 0.25 percentage points from the previous quarter and up 1.71 percentage points year-on-year [3] - The gross profit margin is reported at 10.63%, showing a slight increase of 0.01 percentage points from the previous quarter but a decrease of 1.17 percentage points compared to the same period last year [3] - The return on equity (ROE) is at 0.99%, down 0.41 percentage points from the previous year [3] Earnings Per Share and Turnover Ratios - The diluted earnings per share (EPS) is 0.04 yuan, a decrease of 0.01 yuan from the same period last year, reflecting a year-on-year decline of 28.57% [3] - The total asset turnover ratio is 0.71 times, an increase of 0.02 times from the previous year, indicating a year-on-year growth of 2.54% [3] - The inventory turnover ratio is 2.61 times, up 0.35 times from the previous year, representing a year-on-year increase of 15.37% [3] Shareholder Information - The number of shareholders is 45,800, with the top ten shareholders holding a total of 470 million shares, accounting for 45.51% of the total share capital [3] - The largest shareholder is Qilu Financial Investment Group Co., Ltd., holding 29.91% of the shares [3]